Viavi's $500 Million Stock Sale Cleaned Up Its Balance Sheet — So Why Can't the Stock Stop Falling?

Shares of Viavi Solutions slid 6.9% to $34.40 in pre-market Thursday, extending a punishing week that has erased roughly 20% of the stock's value since July 10. The selloff traces directly to lingering fallout from the company's $500 million equity offering — and a growing sense among investors that the dilution math simply does not add up in their favor.

• More Than 12 Million New Shares Hit an Already Nervous Market. Viavi priced 11,111,111 shares at $45.00 apiece in May , and the underwriters fully exercised their option for an additional 1,666,666 shares . That added roughly 5% to the share count on a base of about 246.7 million shares outstanding . For existing holders, each share now represents a smaller slice of the company's earnings — and with trailing diluted earnings per share of just $0.15 , every fraction of ownership matters.

• The Debt Payoff Is Real, but the Stock Was Already Priced for Perfection. Viavi earmarked the proceeds to repay the $450 million principal on its Term Loan B , with the surplus going to working capital . Eliminating that debt reduces interest costs and simplifies the balance sheet. But the stock had already surged over 300% in the prior twelve months, gaining 129.6% year-to-date alone . At those heights, a dilutive offering gives nervous holders a reason to take profits — and the $45 offering price, now well above the current trade, acts as an overhang (a ceiling of supply from investors who bought the deal and may sell into rallies).

• Insider Selling Adds Fuel to the Skeptics' Case. Insiders have sold $26.5 million worth of shares in the last three months with zero buying . That one-sided activity signals that the people who know the business best are cashing in, compounding outside investors' unease about valuation. Options markets confirm the bearish tilt: 4,858 puts recently traded at roughly 8× expected volume .

• AI Tailwinds Are Strong, but Earnings Must Catch Up. Viavi's growth in AI data-center testing and aerospace/defense segments is real and supports analyst price targets averaging around $64.75 . Yet the company's net profit margin sits at just 3.2% , and analysts project earnings of only $0.98 per share this year . At today's price that implies a forward price-to-earnings ratio near 35× — a steep ask for a company still proving it can convert AI-era demand into bottom-line profit.